Tacrolimus monotherapy in OLT [orthotopic liver transplant] recipients with HCV [hepatitis C virus] under preemptive treatment with interferon and ribavirin
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 18 Nov 2013
At a glance
- Drugs Peginterferon alfa-2b (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 17 Feb 2012 Planned End Date changed from 1 Jul 2009 to 1 Mar 2008 as reported by ClinicalTrials.gov.
- 03 Nov 2009 Actual end date (Mar 2008) added as reported by ClinicalTrials.gov record.
- 03 Nov 2009 Status changed from active, no longer recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.